By Christopher Weaver Abbott Laboratories became the third pharmaceutical giant this week to say its earnings fell because of the health overhaul. The company said yesterday the overhaul slashed its sales by $60 million, and required the firm to write
Read More...
Read the complete post at http://www.npr.org/blogs/health/2010/04/overhaul_means_losses_now_for.html?ft=1&f=103537970
Posted
Apr 22 2010, 12:37 PM
by
NPR Blogs: Shots - Health News